tiprankstipranks
Trending News
More News >
Dr. Martens Plc (GB:DOCS)
LSE:DOCS
UK Market

Dr. Martens Plc (DOCS) Earnings Dates, Call Summary & Reports

Compare
142 Followers

Earnings Data

Report Date
Nov 27, 2025
TBA Not Confirmed
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Earnings Call Date:Jun 05, 2025
|
% Change Since: 35.20%
|
Next Earnings Date:Nov 27, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance with notable achievements in inventory and debt reduction, cost savings, and growth in the Americas D2C and APAC regions. However, significant challenges remain, including overall revenue decline, reduced wholesale revenue, and underperformance in the EMEA D2C market.
Company Guidance
In the recent call, the company provided detailed guidance on their financial performance and strategic objectives for FY '25. They successfully met their four key goals: returning the Americas Direct-to-Consumer (D2C) segment to growth in the second half, achieving GBP 25 million in annualized cost savings, significantly reducing inventory by GBP 67 million (exceeding the GBP 40 million target), and decreasing net debt by GBP 95 million. Revenue for the year was down 8% to GBP 805 million on a constant currency basis. Despite a 9% drop in total pairs sold, the D2C mix improved slightly. Gross margins declined slightly due to changes in product mix, with an emphasis on shoes and sandals over higher-margin boots. Operating costs increased by 2% due to investment in demand generation. Adjusted EBIT stood at GBP 67.1 million, with adjusted PBT at GBP 40.3 million, both slightly surpassing consensus. The company also reported GBP 25.3 million in adjusting items, primarily from exceptional costs associated with a cost action plan. The strategy moving forward focuses on stabilizing the business and setting a foundation for future growth.
Americas D2C Return to Growth
The company's Americas Direct-to-Consumer (D2C) segment returned to growth in the second half of FY '25, indicating a positive turnaround in this market.
Significant Inventory and Debt Reduction
The company reduced inventory by GBP 67 million, surpassing the original target of GBP 40 million, and decreased net debt by GBP 95 million, strengthening the balance sheet significantly.
Cost Savings Achieved
Through a cost action plan, the company achieved GBP 25 million in annualized cost savings, which will be fully realized in FY '26.
Strong Performance in APAC Region
D2C sales in the APAC region showed strong year-on-year growth in Japan, South Korea, and China, with South Korea particularly noted for its performance in Q4.
New Financing Arrangements Secured
The company secured refinancing as announced at the half-year mark, contributing to the stabilization efforts.

Dr. Martens Plc (GB:DOCS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GB:DOCS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 27, 2025
2026 (Q2)
- / -
Jun 05, 2025
2025 (Q4)
0.03 / 0.03
0.051-39.22% (-0.02)
Nov 28, 2024
2025 (Q2)
-0.02 / -0.01
0.019-168.42% (-0.03)
May 30, 2024
2024 (Q4)
0.05 / 0.05
0.084-39.29% (-0.03)
Nov 30, 2023
2024 (Q2)
0.02 / 0.02
0.045-57.78% (-0.03)
Jun 01, 2023
2023 (Q4)
0.10 / 0.08
0.132-36.36% (-0.05)
Nov 24, 2022
2023 (Q2)
0.05 / 0.04
0.048-6.25% (>-0.01)
Jun 01, 2022
2022 (Q4)
0.10 / 0.13
0.08260.98% (+0.05)
Dec 09, 2021
2022 (Q2)
0.05 / 0.05
0.084-42.86% (-0.04)
Jun 17, 2021
2021 (Q4)
- / 0.08
0.164-50.00% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GB:DOCS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jun 05, 2025
59.95p75.40p+25.77%
Nov 28, 2024
57.02p64.77p+13.59%
May 30, 2024
81.65p81.75p+0.12%
Nov 30, 2023
109.72p86.21p-21.43%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Dr. Martens Plc (GB:DOCS) report earnings?
Dr. Martens Plc (GB:DOCS) is schdueled to report earning on Nov 27, 2025, TBA Not Confirmed.
    What is Dr. Martens Plc (GB:DOCS) earnings time?
    Dr. Martens Plc (GB:DOCS) earnings time is at Nov 27, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Dr. Martens Plc stock?
          The P/E ratio of Dr. Martens Plc is N/A.
            What is GB:DOCS EPS forecast?
            Currently, no data Available
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis